Objective
Human immunodeficiency virus type 1 (HIV-1) infection induces the depletion of the CD4-positive T cells in infected persons, leading to AIDS. The currently available treatments for HIV-1 infection do not cure the infection, display many side effects, lead to drug resistance, and are expensive. Consequently, there is a real need to further define the cell host/virus interactions that are either required for viral replication, or are capable of controlling infection. Little is known regarding the changes in cellular gene and microRNA expression that occur in host cells in response to HIV-1 infection. I propose to conduct detailed, time-dependent genome wide analyses of human gene expression in primary cells following HIV-1 infection, by using a combination of micro-arrays and deep sequencing methods. This study will be conducted in primary blood cells (the natural targets of HIV-1 infection) such as resting or activated CD4-positive T cells, monocyte-derived macrophages and monocytes. Reverse transcription in combination with quantitative real-time PCR will be used to validate observed changes in host gene expression. I plan to identify both the viral determinants and the cellular signal transduction pathways responsible for altered gene expression. Finally, I will analyse the functional relevance of the mRNAs and microRNAs induced, with respect to the potential control or suppression of HIV-1 infection. This work will provide new information on the interactions between HIV-1 and infected cells, on the ability of host cells to respond rapidly to virus infection, and on mechanisms of cell-mediated resistance to infection.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance
- natural sciences biological sciences genetics genomes
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-IEF-2008
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
WC2R 2LS London
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.